Trials / Completed
CompletedNCT01357512
Evaluation of Diagnostic Value of 3-T Magnetic Resonance Imaging (MRI) in Suspected Prostate Cancer
Evaluation of Diagnostic Value of 3-T MRI in Suspected Prostate Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- University of Oulu · Academic / Other
- Sex
- Male
- Age
- 40 Years – 72 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the usefulness of 3-T magnetic resonance imaging (MRI) in the evaluation of suspected prostate cancer. Men with suspected prostate cancer based on serum prostate-specific antigen antigen (PSA) value are included. Men are randomized to pre-biopsy MRI or no MRI groups in ratio 1:1. Standard transrectal ultrasound guided biopsies will be taken in addition to extra biopsies from lesions suspicious based on MRI evaluation. Hypothesis is that more prostate cancers will be found after MRI evaluation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | magnetic resonance imaging, Siemens | Magnetic resonance imaging (MRI) of prostate with Siemens 3-tesla device |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2014-12-01
- Completion
- 2017-09-01
- First posted
- 2011-05-20
- Last updated
- 2017-12-02
- Results posted
- 2015-06-17
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT01357512. Inclusion in this directory is not an endorsement.